Canada markets close in 5 hours 34 minutes

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.24-0.25 (-2.38%)
As of 10:26AM EDT. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Premium required to access quarterly data
Quarterly

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2016-12-31
Total Revenue
2,741
4,112
30,482
42,220
35,368
Operating Expenses
Research Development
82,629
88,017
95,258
98,573
88,712
Selling General and Administrative
32,898
27,203
29,315
28,290
23,892
Total Operating Expenses
115,527
115,220
124,573
126,863
112,604
Operating Income or Loss
-112,786
-111,109
-94,091
-84,643
-77,236
Interest Expense
10,748
7,949
-
-
-
Total Other Income/Expenses Net
-102,353
-4,358
-1,628
-5,176
2,238
Income Before Tax
-223,178
-120,809
-94,798
-88,206
-73,740
Income Tax Expense
-87.764
-257.335
2,170
-
0
Income from Continuing Operations
-223,992
-120,552
-96,968
-88,206
-73,740
Net Income
-221,997
-119,359
-96,968
-88,206
-73,740
Net Income available to common shareholders
-221,997
-119,359
-96,968
-88,206
-73,740
Basic EPS
-
-1.21
-1.05
-1.08
-1.01
Diluted EPS
-
-1.21
-1.05
-1.09
-1.01
Basic Average Shares
-
98,718
92,540
81,777
73,215
Diluted Average Shares
-
98,718
92,540
81,918
73,215
EBITDA
-
-107,344
-89,094
-81,174
-74,150